Literature DB >> 8450455

Potassium channel blocking properties of propafenone in rabbit atrial myocytes.

D Duan1, B Fermini, S Nattel.   

Abstract

Propafenone, a class 1c antiarrhythmic agent, is known to be a potent blocker of voltage-dependent sodium channels; however, several clinical actions of the drug point toward possible potassium channel blocking capability. The present experiments were designed to assess the extent and potential mechanisms of potassium channel blocking properties of propafenone. Whole-cell voltage-clamp techniques were used to define the actions of propafenone on the transient outward current (Ito), the delayed rectifier current (Ik) and the inward rectifier current (Ik1) in isolated rabbit atrial myocytes. Propafenone blocked all three currents, with the extent of blockade being independent of test potential During depolarizing voltage steps, block of Ito and Ik developed as an exponential function of time, consistent with time-dependent open channel blockade. The rate constant of block onset was concentration dependent. The inactivation of Ito was a monoexponential function of time under control conditions, with a time constant averaging 19.1 +/- 1.3 msec (mean +/- S.E.) at +10 mV. Propafenone accelerated Ito inactivation, resulting in a biexponential process having time constants of 5.1 +/- 0.9 (P < .001 vs. control) and 23.5 +/- 2.0 msec (P = N.S. vs. control) at 5 microM and 3.4 +/- 0.5 (P < .001 vs. control) and 28.5 +/- 4.3 msec (P = N.S.) at 10 microM concentrations, respectively. The rapid phase inactivation time constants were of the same order as time constants for the onset of block (3.1 +/- 0.6 and 1.8 +/- 0.3 msec at 5 and 10 microM respectively), suggesting that the acceleration of Ito inactivation was due to open channel block by the drug. The IC50 for blockade was substantially less for effects on Ik (0.76 microM; 95% confidence limits 0.44-1.30 microM) than for Ito (5.91 microM; 95% confidence limits 4.19-8.33 microM) or Ik1 (7.10; 5.24-9.61 microM). We conclude that 1) propafenone is an efficacious potassium channel blocker; 2) propafenone blockade of time-dependent potassium currents is open-state dependent; and 3) propafenone block of potassium currents is relatively selective for Ik.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450455

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Effects of propafenone on K currents in human atrial myocytes.

Authors:  A Seki; N Hagiwara; H Kasanuki
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Molecular mechanisms of regulation of fast-inactivating voltage-dependent transient outward K+ current in mouse heart by cell volume changes.

Authors:  Guan-Lei Wang; Ge-Xin Wang; Shintaro Yamamoto; Linda Ye; Heather Baxter; Joseph R Hume; Dayue Duan
Journal:  J Physiol       Date:  2005-08-04       Impact factor: 5.182

Review 3.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

4.  Modulation of 4-AP block of a mammalian A-type K channel clone by channel gating and membrane voltage.

Authors:  J A Yao; G N Tseng
Journal:  Biophys J       Date:  1994-07       Impact factor: 4.033

5.  Mechanical and electrophysiological effects of 8-oxoberberine (JKL1073A) on atrial tissue.

Authors:  J F Chi; S H Chu; C S Lee; N K Chou; M J Su
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 6.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

7.  Docosahexaenoic acid has influence on action potentials and transient outward potassium currents of ventricular myocytes.

Authors:  Ru-xing Wang; Xiao-rong Li; Tao Guo; Li-ping Sun; Su-xia Guo; Zhen-Yu Yang; Xiang-Jun Yang; Wen-ping Jiang
Journal:  Lipids Health Dis       Date:  2010-04-17       Impact factor: 3.876

8.  Effects of flecainide and quinidine on Kv4.2 currents: voltage dependence and role of S6 valines.

Authors:  Ricardo Caballero; Marc Pourrier; Gernot Schram; Eva Delpón; Juan Tamargo; Stanley Nattel
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

9.  Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation.

Authors:  Niels Voigt; Nadiia Rozmaritsa; Anne Trausch; Thomasz Zimniak; Torsten Christ; Erich Wettwer; Klaus Matschke; Dobromir Dobrev; Ursula Ravens
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-17       Impact factor: 3.000

10.  Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.

Authors:  Noriyuki Hatano; Susumu Ohya; Katsuhiko Muraki; Wayne Giles; Yuji Imaizumi
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.